Christiana Marie Cioffi
CIK: 0002043411
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FENNEC PHARMACEUTICALS INC.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Oct 31, 2026FENC
FENNEC PHARMACEUTICALS INC.
Award(A)Direct156 shares- - Oct 12, 2026FENC
FENNEC PHARMACEUTICALS INC.
Award(A)Direct3.9K shares at avg. $5.53$22K - Sep 30, 2026FENC
FENNEC PHARMACEUTICALS INC.
Award(A)Direct156 shares- - Aug 31, 2026FENC
FENNEC PHARMACEUTICALS INC.
Award(A)Direct156 shares- - Jul 31, 2026FENC
FENNEC PHARMACEUTICALS INC.
Award(A)Direct156 shares- - Jun 30, 2026FENC
FENNEC PHARMACEUTICALS INC.
Award(A)Direct156 shares- - May 31, 2026FENC
FENNEC PHARMACEUTICALS INC.
Award(A)Direct156 shares- - Apr 30, 2026FENC
FENNEC PHARMACEUTICALS INC.
Exercise(M)Direct155 shares- - Mar 31, 2026FENC
FENNEC PHARMACEUTICALS INC.
Exercise(M)Direct158 shares- - Mar 31, 2026FENC
FENNEC PHARMACEUTICALS INC.
Exercise(M)Direct17.1K shares- - Mar 31, 2026FENC
FENNEC PHARMACEUTICALS INC.
Award(A)DirectStock Options
120K shares at avg. $5.77- - Mar 28, 2026FENC
FENNEC PHARMACEUTICALS INC.
Exercise(M)Direct1.9K shares- - Mar 26, 2026FENC
FENNEC PHARMACEUTICALS INC.
Exercise(M)Direct4.7K shares at avg. $4.23$20K - Mar 28, 2025FENC
FENNEC PHARMACEUTICALS INC.
Award(A)DirectRestricted Share Unit
10K shares- - Mar 28, 2025FENC
FENNEC PHARMACEUTICALS INC.
Award(A)DirectRestricted Share Unit
10K shares- - Nov 13, 2024FENC
FENNEC PHARMACEUTICALS INC.
Award(A)DirectStock Options
150K shares at avg. $4.23-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) | 156 | - | $0 | Direct |
| Oct 12, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) | 3,946 | $5.53 | $21,821 | Direct |
| Sep 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) | 156 | - | $0 | Direct |
| Aug 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) | 156 | - | $0 | Direct |
| Jul 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) | 156 | - | $0 | Direct |
| Jun 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) | 156 | - | $0 | Direct |
| May 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) | 156 | - | $0 | Direct |
| Apr 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Exercise(M) | 155 | - | $0 | Direct |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Exercise(M) | 158 | - | $0 | Direct |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Exercise(M) | 17,106 | - | $0 | Direct |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) Stock Options | 120,000 | $5.77 | - | Direct |
| Mar 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Exercise(M) | 1,901 | - | $0 | Direct |
| Mar 26, 2026 | FENC FENNEC PHARMACEUTICALS INC. | Exercise(M) | 4,700 | $4.23 | $19,881 | Direct |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) Restricted Share Unit | 10,000 | - | - | Direct |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) Restricted Share Unit | 10,000 | - | - | Direct |
| Nov 13, 2024 | FENC FENNEC PHARMACEUTICALS INC. | Award(A) Stock Options | 150,000 | $4.23 | - | Direct |
1-16 of 16 transactions
About Cioffi Christiana Marie
Cioffi Christiana Marie (SEC CIK 0002043411) files insider reports with the SEC as Chief Strategy Officer of FENNEC PHARMACEUTICALS INC. (FENC).
Signal8 holds 14 ownership filings by Cioffi Christiana Marie (1 Form 3, 13 Form 4), filed between Nov 4, 2024 and Nov 2, 2026. Those filings report 16 transactions, from Nov 13, 2024 to Oct 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cioffi Christiana Marie's filings is in RESEARCH TRIANGLE PARK, NC.
Recent filings by Cioffi Christiana Marie
- Oct 31, 2026: Grant or award of FENC shares (Form 4, code A).
- Oct 12, 2026: Grant or award of FENC shares (Form 4, code A).
- Sep 30, 2026: Grant or award of FENC shares (Form 4, code A).
- Aug 31, 2026: Grant or award of FENC shares (Form 4, code A).
- Jul 31, 2026: Grant or award of FENC shares (Form 4, code A).
Other insiders filing for FENNEC PHARMACEUTICALS INC. (FENC)
- Evans Terry L, Chief Commercial Officer
- Sayad Pierre Sargis, Chief Medical Officer
- Hackman Jeffrey S., Chief Executive Officer
- Andrade Robert, CHIEF FINANCIAL OFFICER
- Brughera Marco Maria, Director
- Raykov Rosty, Officer